Adjunctive Methods in the Treatment of Cancer
E-Book, Englisch, 312 Seiten, ePub
ISBN: 978-3-13-257954-5
Verlag: Thieme
Format: EPUB
Kopierschutz: Wasserzeichen (»Systemvoraussetzungen)
Complementary methods have played an important role in these treatments, showing benefits such as a higher quality of life, reduced instance and severity of the side effects of standard therapy, and a general improvement of the patient's immunological state. Indeed, these methods - from carefully monitored nutrition, exercise, and psychological support to enzyme substitution, phytotherapy, hyperthermia and microbiology therapy - are critical to a treatment's overall success.
More than ever, doctors need accurate, up-to-date information about which methods have been proven in scientifically based clinical studies (EBM) to be acceptable for use in conjunction with standard treatment methods. In this unique book, experts ranging across medical disciplines present data on the efficacy of these methods as they are currently being used, the necessary scientific background, and practical advice for introducing them into practice. With illustrations, tables, and detailed descriptions, this book is an ideal reference and an invaluable tool for educating patients about this encouraging aspect of cancer therapy.
Throughout, the contributors emphasize the latest scientifically and clinically tested treatments. A useful chart lays out in detail which treatments are applicable for various types of cancers and what effects they have been shown to cause.
The word is out about the beneficial qualities of complementary therapies in the treatment of cancer. More physicians are offering it to their patients, and more and more patients are demanding it. You - and your patients - cannot afford to be without this valuable resource.
Zielgruppe
Ärzte
Autoren/Hrsg.
Fachgebiete
Weitere Infos & Material
1 Introduction to Complementary Medicine in Oncology
2 The Conventional Treatment of Cancer: The Case of Non-Small Cell Lung Cancer
3 Tumor Immunology
4 Introduction to Medical Biometry
5 Expert Systems in Complementary Oncology
6 Observational Studies on Drugs Efficacy
7 Electronically Supported Outcome Measurement
8 Cancer and Nutrition
9 Exercise in Cancer Prevention and Follow-up
10 Psycho-oncology
11 Biological Basis for Using High Dose Multiple Antioxidants as an Adjunct to Radiotherapy, Chemotherapy, and Experimental Cancer Therapies
12 Selenium in Oncology
13 Proteolytic Enzymes
14 Lectin-Standardized Mistletoe Extracts
15 Mistletoe Extracts from the Anthroposophical Point of View
16 Thymic Peptides
17 Probiotic Therapy
18 Blockade of Adhesion Molecules
19 Tumor Vaccination and Antibody-Mediated Immuno-therapy
20 Hyperthermia
21 Applied Complementary Oncology
22 Advances in Oncology—From Research to Application
List of Abbreviations
a-TS a-tocopherol succinate ADCC antibody-dependent cellular cytotoxicity AJCC American Joint Committee on Cancer APC antigen-presenting cell ASCO American Society of Clinical Oncology ASI active specific immunotherapy (for cancer) ATBC a-tocopherol plus ß-carotene ATRA all-transretinoic acid ATV autologous tumor vaccine AVI autovaccine for intestinal tract AWB Anwendungsbeobachtungen (specific observational studies; a German variant of postmarketing surveillance studies) BALT bronchus-associated lymphoid tissue BCG bacillus of Calmette-Guerrin BfArM Federal Institute for Drugs and Medical Devices BSC best supportive care CALGB Cancer and Leukemia Group B CAM complementary and alternative medicine CAP catabolite activation protein CARET ß-Carotene and Retinol Efficacy Trial CDC complement-dependent cytotoxicity CHART continuous hyperfractionated accelerated radiotherapy CMF cyclophosphamide, methotrexate, fluorouracil (chemotherapy) CML chronic myeloid leukemia CR complete remission CRF case report forms CTL cytotoxic lymphocyte DACH German, Austrian, and Swiss Societies of Nutrition DC dendritic cells DGE German Society of Nutrition DHA dehydroascorbic acid DHT deep hyperthermia DNA deoxyribonucleic acid DRI dietary reference intake DTH delayed-type hypersensitivity DTIC 5-(3,3-dimethyl-1-triazeno)-imidazol-4-carboximide (dacarbazine) EBM evidence-based medicine EBV Epstein–Barr virus ECOG Eastern Collaborative Oncology Group EGCG epigallocatechin gallate EGF epidermal growth factor EGFR epidermal growth factor receptor EMEA European Agency for the Evaluation of Medicinal Products FDA Food and Drug Administration FGF fibroblast growth factor FKJ fine-needle catheter jejunostomy GAC germ-free animal characteristics Gal galactose GalNAc N-acetyl-D-galactosamine GCP good clinical practices (placebo controlled, prospective randomized, double-blind multicenter study) GEP good epidemiological practices GM-CSF granulocyte–macrophage colonystimulating factor GSH-Px glutathione peroxidase HAA heterocyclic aromatic amines HADS Hospital Anxiety and Depression Scale HAMA human antimouse antibody HBP hepatic binding protein HL hepatic lectin HLA human lymphocyte antigen HRQOL health-related quality of life HSP heat shock protein ICH International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use ICHP intracavitary hyperthermic perfusion (perfusion hyperthermia) IHT interstitial hyperthermia IL interleukin IMS Institute for Medical Statistics iNO inducible nitric oxide synthetase IOM Institute of Medicine IPHP intraperitoneal hyperthermic perfusion IplHP intrapleural hyperthermic perfusion IRA infrared-A radiation IRB Institutional Review Board ISGNAS International Study Group of New Antimicrobial Strategies ITT intention-to-treat analysis IVHP intravesicular hyperthermic perfusion JNCI Journal of the National Cancer Institute LAK lymphokine-activated killer cell LCL lymphoblastoid cell line LHT local hyperthermia LPS lipopolysaccharide MAC microflora-associated characteristics Mab monoclonal antibody MALT mucosa-associated lymphoid tissue MCP-1 monocyte chemotactic protein 1 MFH magnetic fluid...
